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Cardiovascular diseases (CVDs) prevalence continues to
increase, and it is still the number one killer so far. In 2002,
nearly 17 million deaths all over the world were attributable
to CVDs, which accounted for almost 30% of the total
deaths. Despite treatment with percutaneous coronary inter-
vention (PCI) and many other conventional medicines,
CVDs patients are still confronted with certain risk of re-
current acute cardiovascular events, readmission to the
hospital, and unfavorable quality of life. In recent years,
more and more clinicians have successfully applied comple-
mentary/alternative medicine (CAM) in CVDs prevention
and treatment based on standardized conventional therapy.
Nevertheless, the role of CAM in CVDs still needs more
clinical evidence and deﬁnite mechanism of actions.
In this issue, a collection of several original research ar-
ticles and reviews are presented that address the clinical
application and the mechanism of action of CAM in the
treatmentofCVDs.Theseworksweresubmittedbyresearch-
ers from diﬀerent parts of the world, including China,
Japan, South Korea, Australia, and Sweden. In these studies,
the eﬀectiveness of Chinese medicine and some other
alternative therapeutic methods in improving symptoms
was demonstrated in patients with hypertension, chronic
stable coronary artery disease, chronic heart failure, and so
forth. Speciﬁcally, the use of Chinese herbal medicines was
reviewed for the prevention of in-stent coronary restenosis
after PCI. The study of Tanshinone IIA, a diterpene quinine
extracted from the root of salvia miltiorrhiza, a Chinese
traditional herb, was presented as a promising cardiopro-
tective agent. The positive eﬀect of Chinese food and herbal
medicines in improving certain moderate dyslipidemias was
described. The usefulness of Xuezhikang, an extract from
Red Yeast Rice, was reviewed in the treatment of coronary
heart disease complicated by dyslipidemia. A pharmaco-
logical and mechanistic study showed Naoxintong’s eﬀect
on cytochrome P450 2C19. Further, one study showed
the eﬀect of berberine on improving insulin sensitivity
by inhibiting fat store and adjusting adipokines proﬁle in
human preadipocytes and metabolic syndrome patients.
In the authors’ opinion, the clinical research of Chinese
medicine and other CAMs for CVDs still faces some major
challenges. Issues such as overall quality of medical service
and the unmet medical needs in the contemporary society
are common to these medicines. A general guideline is
required for practicing Chinese medicine and other CAMs,
which should be developed based on solid evidence from
well-designed and well-executed clinical studies. Such is the
direction that the research of Chinese Medicine and other
CAM should follow.
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